Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab plus chemotherapy in advanced soft tissue sarcoma
NCT04589754Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2021
- Primary completion
- Dec 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in soft tissue sarcoma (STS), sponsored by Sun Yat-sen University. Started Jul 2021; status: recruiting.
02
Drugs
sintilimab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04589754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589754.